FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
2.250
+0.220 (10.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
FibroBiologics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 8.58 | 6.52 | 3.32 | 1.06 | 0.5 |
| Research & Development | 3.92 | 2.37 | 1.15 | 0.52 | 0.67 |
| Operating Expenses | 12.51 | 8.89 | 4.47 | 1.58 | 1.17 |
| Operating Income | -12.51 | -8.89 | -4.47 | -1.58 | -1.17 |
| Interest Expense | -0.02 | -0.15 | -0.65 | -0 | - |
| Other Non Operating Income (Expenses) | -5.45 | -7.45 | - | - | - |
| Pretax Income | -17.78 | -16.49 | -5.12 | -1.58 | -1.17 |
| Net Income | -17.78 | -16.49 | -5.12 | -1.58 | -1.17 |
| Preferred Dividends & Other Adjustments | - | 2.57 | - | - | - |
| Net Income to Common | -17.78 | -19.06 | -5.12 | -1.58 | -1.17 |
| Shares Outstanding (Basic) | 31 | 28 | 28 | 9 | 9 |
| Shares Outstanding (Diluted) | 31 | 28 | 28 | 9 | 9 |
| Shares Change (YoY) | 11.23% | - | 222.64% | - | - |
| EPS (Basic) | -0.57 | -0.68 | -0.18 | -0.18 | -0.13 |
| EPS (Diluted) | -0.57 | -0.68 | -0.18 | -0.18 | -0.13 |
| Free Cash Flow | -10.52 | -6.9 | -4.07 | -1.41 | -1.17 |
| Free Cash Flow Per Share | -0.33 | -0.24 | -0.14 | -0.16 | -0.13 |
| EBITDA | -12.36 | -8.84 | - | - | - |
| D&A For EBITDA | 0.14 | 0.05 | - | - | - |
| EBIT | -12.51 | -8.89 | -4.47 | -1.58 | -1.17 |
Source: S&P Capital IQ. Standard template.
Financial Sources.